We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCN icon
476
FTI Consulting
FCN
$5.14B
– –
-3,242
Closed -$682K
FDMT icon
477
4D Molecular Therapeutics
FDMT
$502M
– –
-8,821
Closed -$281K
FIVE icon
478
Five Below
FIVE
$11.6B
– –
-2,232
Closed -$405K
FLGT icon
479
Fulgent Genetics
FLGT
$558M
– –
-10,959
Closed -$238K
FRSH icon
480
Freshworks
FRSH
$3.21B
– –
-16,036
Closed -$292K
GCO icon
481
Genesco
GCO
$434M
– –
-19,786
Closed -$557K
GES
482
DELISTED
Guess Inc
GES
– –
-16,226
Closed -$511K
GH icon
483
Guardant Health
GH
$19.1B
– –
-791,735
Closed -$16.3M
GLW icon
484
Corning
GLW
$107B
– –
-14,817
Closed -$488K
GM icon
485
General Motors
GM
$80.9B
– –
-8,774
Closed -$398K
GPI icon
486
Group 1 Automotive
GPI
$4.26B
– –
-1,007
Closed -$294K
GPRO icon
487
GoPro
GPRO
$120M
– –
-175,149
Closed -$391K
HALO icon
488
Halozyme
HALO
$9.88B
– –
-11,042
Closed -$449K
HCSG icon
489
Healthcare Services Group
HCSG
$1.61B
– –
-46,036
Closed -$575K
HIMS icon
490
Hims & Hers Health
HIMS
$5.79B
– –
-10,521
Closed -$163K
HQY icon
491
HealthEquity
HQY
$8.71B
– –
-4,660
Closed -$380K
HRMY icon
492
Harmony Biosciences
HRMY
$2.08B
– –
-8,420
Closed -$283K
HURN icon
493
Huron Consulting
HURN
$2.76B
– –
-4,015
Closed -$388K
IHRT icon
494
iHeartMedia
IHRT
$531M
– –
-131,552
Closed -$275K
IMNM icon
495
Immunome
IMNM
$2.62B
– –
-23,031
Closed -$568K
INCY icon
496
Incyte
INCY
$25.4B
– –
-6,672
Closed -$380K
IR icon
497
Ingersoll Rand
IR
$33.1B
– –
-5,065
Closed -$481K
IRTC icon
498
iRhythm Holdings
IRTC
$4.02B
– –
-2,702
Closed -$313K
ITT icon
499
ITT
ITT
$17.1B
– –
-3,774
Closed -$513K
J icon
500
Jacobs Solutions
J
$16B
– –
-2,928
Closed -$372K
18 19
20
21 22

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.